A Phase Ib Trial of Eribulin in Combination With Irinotecan and Temozolamide in Children With Relapsed or Refractory Solid Tumors

NCT06006273 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Refractory Solid Tumors

Interventions

DRUG: Eribulin
DRUG: Irinotecan
DRUG: Temozolomide

Sponsor

M.D. Anderson Cancer Center